Carboplatin + Etoposide
Treatment for Tracheal Bronchus And Lung Cancer
Typical Dosage: Carboplatin AUC 5-6 IV Day 1; Etoposide 100-120 mg/m2 IV Days 1-3, every 3 weeks
Effectiveness
55%
Safety Score
25%
Clinical Trials
500
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
Carboplatin AUC 5-6 IV Day 1; Etoposide 100-120 mg/m2 IV Days 1-3, every 3 weeks
Time to Effect
1-2 months
Treatment Duration
4-6 cycles (approx. 3-4 months)
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15,000
Monitoring:$5,000
Side Effect Mgmt:$10,000
Total Annual:$30,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$46,154
Cost per Remission
$300,000
Carboplatin + Etoposide Outcomes
for Tracheal Bronchus And Lung Cancer
Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+65%
Remission Rate
+10%
Common Side Effects
Myelosuppression (Neutropenia, Thrombocytopenia, Anemia)
+90%
Nausea/Vomiting
+80%
Fatigue
+70%
Alopecia
+70%
Peripheral Neuropathy
+20%
Mucositis
+20%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov